iWEECARE adds US$2.4M its coffers to accelerate growth of its remote wearable thermometer
iWEECARE, a Taiwanese startup the has developed a smart thermometer called Temp Pal, announced today it has raised US$2.4 million in extended pre-Series A financing, led by TransLink Capital, a Silicon Valley-based VC firm with a specific focus on Asia.
The round also saw investment from Taiwan’s National Development Fund, BE Capital, Taiwan Surface Mounting Technology Corp, NCTU Angel Club, Might Electronic, and existing investors Verge HealthTech Fund (Singapore) and Darwin Venture (Taiwan).
The funds will be used to accelerate marketing activities to address the demand for remote patient monitoring technologies in the US and China.
iWEECARE’s Temp Pal is a remote wearable thermometer initially developed to assist in pregnancy planning and baby care. The product has received medical certification in Europe, Singapore, Thailand, and Taiwan.
Temp Pal has already been deployed in China, Ireland, Japan, Thailand, and Taiwan as a solution to mitigate the risk of COVID-19 infection and reduce the burden on health systems by reducing the physical contact between caregivers and their patients, the startup said in a press release.
iWEECARE’s Co-founder and CEO Glen Tseng said: “Temp Pal received an overwhelming amount of inquiries for coronavirus use from the US and China earlier this year. The new funding will be used in accelerating our global footprint to satisfy the demands from these markets and ultimately improve patient safety and outcomes.”
TransLink Capital Co-founder Jackie Yang said: “Under the COVID-19 pandemic and shift to remote patient monitoring, we see huge potential for iWEECARE to expand globally. We hope the new investment can help the brand to develop and establish an international presence.”
In July 2019, iWEECARE secured US$1 million in pre-Series A round of investment, led by Verge HealthTech Fund.